Clinical Scorecard: Practice Management for Photobiomodulation of the Retina

At a Glance

Key Highlights

• PBM received FDA authorization in November 2023.
• PBM shows potential to improve visual function compared to traditional treatments.
• Medicare does not cover facility fees for PBM.
• CPT code 0936T was introduced for billing PBM procedures.
• PBM should not be administered by medical assistants or ophthalmic technicians.

Guideline-Based Recommendations

Diagnosis

Management

Monitoring & Follow-up

• Monitor visual function using standardized metrics and assess any changes in AMD status post-PBM.

Risks

Patient & Prescribing Data

Patients diagnosed with intermediate dry AMD.

PBM is a non-invasive treatment option that may enhance visual function.

Clinical Best Practices

• Verify state regulations regarding the administration of PBM.
• Use CPT code 0936T for billing PBM procedures.
• Document any separate reasons for eye exams performed on the same day as PBM.
• Ensure patient consent is documented prior to PBM treatment.

References

• FDA Authorization of Valeda Light Delivery System
• CPT Code Information